The most common grade @-@ haematological adverse event was neutropenia ( @ -LSB- @ % -RSB- of @ patients in the UFT group , @ -LSB- @ % -RSB- of @ in the S-@ group , @ -LSB- @ % -RSB- of @ in the paclitaxel then UFT group , and @ -LSB- @ % -RSB- of @ in the paclitaxel then S-@ group ) .